Osteoblasts are specialized mesenchymal cells that synthesize bone matrix and coordinate
the mineralization of the skeleton. These cells work in harmony with osteoclasts, which …

Lipocalin-2 (LCN2), also known as neutrophil gelatinase-associated lipocalin (NGAL), is
released by various cell types and is an attractive biomarker of inflammation, ischemia …

Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The
prevailing view is that non-alcoholic steatohepatitis (NASH) and fibrosis or cirrhosis are …

Nonalcoholic fatty liver disease (NAFLD) is a very common hepatic pathology featuring
steatosis and is linked to obesity and related conditions, such as the metabolic syndrome …

Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of liver disorders, from fatty
liver to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma …

Background & Aims Acute-on-chronic liver failure (ACLF) is a syndrome that occurs in
cirrhosis characterized by organ failure (s) and high mortality rate. There are no biomarkers …

Abstract Lipocalin-2 (LCN2) is an acute phase protein with multiple functions that has
garnered a great deal of interest over the last decade. However, its precise role in the …

Background Recent clinical and basic research implicated a strong correlation between
NAFLD/NASH phenotypes with ectopic manifestations including neuroinflammation and …

Lipocalin 2 (LCN2) is a secreted protein that belongs to the Lipocalins, a group of
transporters of small lipophilic molecules such as steroids, lipopolysaccharides, iron, and …

The enrichment of innate immune cells and the enhanced inflammation represent the
hallmark of non-alcoholic steatohepatitis (NASH), the advanced subtype with a significantly …